Author Archives: "Coach" Israel Barken M.D.

Cryo Immunotherapy Part 2

Part 2 of the lecture about Cryo Immune Therapy given by Dr. Israel  Barken from the Prostate Research and Education Foundation.  Dr. Barken describes Cryo immunotherapy. The reasons why there are no consistent immune response after cryoablation are discussed.  Suggestions … Continue reading

Posted in Cryo Immunotherapy, Cryoablation, Prostate Cancer, Treatments for Prostate Cancer | Leave a comment

Cryo Immunotherapy Part 1

Dr. Barken presents the history of cryoablation and the new developments in the field of immunology which will create enhancement of the Immune effect on metastatic disease in response to cryoablation of local tumor.

Posted in Cryo Immunotherapy, Cryoablation, Immune Therapy, Metastatic Disease, Metastatic Prostate Cancer Disease, Treatments for Prostate Cancer, Vaccine | Leave a comment

Cryoablation Immuno Therapy

Clinical Study Phase I Cryoimmunotherapy against Metastatic prostate Cancer Disease. Dr. Israel Barken, the Medical Director of the Prostate Cancer Research and Education, presents a clinical study phase I, featuring cryosurgery plus immuno-Modulator – Cyclophosphamide and Anti CTLA 4 Antibodies- … Continue reading

Posted in Castration Resistant Prostate Cancer, Clinical Trials, Immune Therapy, Prostate Cancer, Treatments for Prostate Cancer, Vaccine | Leave a comment

Combining active immunotherapy and immune checkpoint inhibitors in prostate cancer

Phase I study approach of priming the immune system with Prostvac vaccination, intensified immunotherapy with Ipilimumab to further enhance the immune response.  This was presented by Hapreet Singh M.D. from the National Cancer Institute. Genentech video explaining the “Security Checkpoint System” … Continue reading

Posted in Ask Dr. Barken, Immune Therapy, Metastatic Prostate Cancer Disease, Treatments for Prostate Cancer, Vaccine | Leave a comment

Percentage Involved Core Length and Risk of Recurrence After Radical Prostatectomy

Article: Greatest Percentage Involved Core Length and Risk of Clinically Significant Prostate-Specific Antigen Failure After Radical Prostatectomy. Author:  Anthony V. D’Amico Source: Clinical Genitourinary Cancer.  March 5, 2015

Posted in Biopsy, Prognosis, Prostate Cancer, PSA, Survival prostate cancer, Treatments for Prostate Cancer | Leave a comment

Active Surveillance In Intermediate-Risk Prostate Cancer

Active Surveillance In Intermediate-Risk Prostate Cancer Called Into Question. https://youtu.be/dBk3z2T9KwQ Dr. Israel Barken brings info about higher risk of cancer specific mortality in the intermediate prostate cancer risk group. The study presentor at the GenitoUrinary Symposium 2015 was Dr. Andrew … Continue reading

Posted in Active Surveillance, Treatments for Prostate Cancer | Tagged , | 1 Comment

Testosterone and the risk of cancer.

Testosterone and the risk of cancer. Dr. Israel Barken , the medical director of the prostate cancer research and education foundation PCREF discusses a recent article in the BJU Int. 2015 Feb;115(2):317-21.. Testosterone therapy and cancer risk. Eisenberg ML1, Li … Continue reading

Posted in Testosterone | Tagged , , | Leave a comment

Circulating Epithelial Tumor Cells and Tumor Spheres

Circulating Epithelial Tumor Cells (CETC) and Tumor Spheres. Discussion with Prof. Katharina Pachmann, Ph.D, M.D who is the medical Doctor in Jena University Hopital’s Department of Experimental Hematology and Oncology.  She is an expert on Circulating Epithelial Tumor Cells. The … Continue reading

Posted in Cancer Stem Cells, CETC, CTC, Prognosis, Prostate Cancer, Treatments for Prostate Cancer, Tumor Spheres | Leave a comment

Prostvac Vaccination for Localized Prostate Cancer Disease

Prostvac in Preventing Disease Progression in Patients with Localized Cancer Undergoing Active Surveillance. What is unique about  this vaccine study , is the fact that it is given to patients with localized disease.  Practically, the patient gets a series of vaccination … Continue reading

Posted in Active Surveillance, Clinical Trials, Immune Therapy, Treatments for Prostate Cancer, Vaccine | Tagged , | Leave a comment

What is Liquid Biopsy- The Role of Exosomes

Liquid Biopsy – The Role of Exosomes. Dr. Israel Barken introduces the videos published by Life Technologies from ThermoFisher Technologies. The introduction relates to the importance of using imaging and markers to define recurrent disease and monitor the progression. The … Continue reading

Posted in Biomarker, CETC, CTC, Exosome, Genome, Imaging, Liquid Biopsy, Markers, Treatments for Prostate Cancer | Tagged | Leave a comment